radotinib inn trade name supect sometimes referred investigational name drug treatment different types cancer notably philadelphia chromosomepositive ph chronic myeloid leukemia resistance intolerance bcrabl tyrosinekinase inhibitors patients resistant intolerant imatinib radotinib developed ilyang pharmaceutical co ltd south comarketed daewoong pharmaceutical co ltd south radotinib completed multinational phase ii clinical trial study august ilyang initiated phase iii multinational multicenter openlabel randomized study firstline mechanism action involves inhibition bcrabl tyrosine kinase plateletderived growth factor receptor antineoplastic immunomodulatory drug article stub help wikipedia expanding ithttpsenwikipediaorgwikiradotinib